Keep Current with the Latest in Cell Biology Research
Block title
Cancer Stem Cell Plasticity: Mechanisms, Immune Microenvironment Crosstalk, and Therapeutic Implications
[Journal of Hematology & Oncology] The authors summarize recent advances in our understanding of CSC plasticity, with a particular focus on the bidirectional interplay between CSCs and the tumor immune microenvironment.
LEF1 and Niche Factors Determine T Cell Stemness across Chronic Diseases
[Cell] Using preclinical models of autoimmune type 1 diabetes and chronic infection, researchers discovered that a small subset of TCF1hi T cells express the transcription factor LEF1. LEF1+ TCF1hi T cells define a true self-renewing T cell pool.
Progressive Intestinal Tumor Cell Plasticity, Myc Activation, and Loss of Lgr5 Tumor Stem Cell Lineage Commitment Upon Wnt Depletion
[Science Advances] Scientists demonstrated that a plastic cell state (PSC) is present already in polyps from patients with familial adenomatous polyposis and in mouse intestinal adenomas, in which PCS is associated with PROX1+ tumor stem cells.
ENO2 Sustains Cancer Stemness and Metastatic Competence through a Phosphoenolpyruvate-Dependent Metabolic Axis in Triple-Negative Breast Cancer
[Cell Death & Disease] Investigators demonstrated that Enolase 2 (ENO2) sustains CSC properties and metastatic competence through a phosphoenolpyruvate-dependent metabolic axis.
$2.5 Million Department of Defense Grant Funds Development of Targeted Therapy for Triple-Negative Breast Cancer
[Weill Cornell Medicine] Weill Cornell Medicine has received a $2.5 million, three-year grant from the Department of Defense to develop therapies with fewer side effects for triple-negative breast cancer.
Targeting Mitotic Kinesin KIF20A: A Differentiation-Based Therapeutic Strategy for Glioblastoma Stem/Progenitor Cells
[Stem Cell Reports] Researchers investigated the therapeutic potential of targeting mitotic kinesin KIF20A in glioblastom stem/progenitor cells. KIF20A is a crucial component of cytokinetic machinery and cooperates with a network of cell fate regulators to balance proliferative and differentiative divisions in neural stem/progenitor cells.
Rbm5 Sustains Leukemia Stem Cells through a Myc-Driven Transcriptional Circuitry
[Leukemia] Investigators showed that Rbm5 selectively promotes murine leukemogenesis, and maintains leukemia stem cell (LSC) self-renewal in vivo. Rbm5 is highly expressed in LSCs, and its deficiency results in specifically defective LSC function, along with inhibition of self-renewal gene expression and induction of myeloid differentiation.
PAPOLA-Mediated Hyperactive Polyadenylation Promotes Leukemogenesis and Leukemia Stem Cell Self-Renewal through Metabolic Reprogramming
[Nature Cancer] Using primary acute myeloid leukemia samples, leukemia cell lines and multiple mouse models, scientists demonstrated that PAPOLA-driven hyperactive polyadenylation promotes leukemogenesis and sustains leukemia stem cell maintenance.
Stem-Like Precursors of Exhausted Th Cells Upheld by a Tox-Myb-Eomes Transcriptional Hierarchy Propagate Th Cell Responses in Chronic Infection
[Immunity] The authors identified a population of CD4+ T cells that expressed CD62L and the inhibitory receptor PD-1 and exhibited both features of exhaustion and stemness. These cells acted as precursors of T helper cells and sustained Th cell immunity during chronic lymphocytic choriomeningitis virus infection.
Atypical Chemokine Receptor 3 Regulates Synaptic Removal in Disease Astrocytes
[Molecular Neurodegeneration] Investigators demonstrated that the Atypical chemokine receptor 3 is a major player of astrocyte-mediated synapse engulfment.
AQP4-Dependent Enhancement of Glymphatic Function Attenuates Tau Pathology and Neurodegeneration in PS19 Mice
[Molecular Neurodegeneration] Researchers showed that enhancing AQP4-dependent glymphatic function reduces tau pathology and neurodegeneration, identifying glymphatic modulation as a promising therapeutic strategy for tau-related brain disorders.
MARCKS As a Mediator and Target for Pathological Tunneling Nanotubes Between Patient-Derived Glioblastoma Cells and Astrocytes
[Cell Death & Disease] The authors demonstrated a role for the Myristoylated Alanine Rich C-Kinase Substrate (MARCKS) effector domain and PKC activation in the formation and functionality of tunneling nanotubes between PTEN-null glioblastoma brain tumor–initiating cells and normal human astrocytes.

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
